Tissue-derived acellular micro-scaffold technology reducing or eliminating diabetics’ dependence on insulin therapy

Project Information

Io-EMP

Grant agreement ID: 790461

DOI 10.3030/790461

Closed project

EC signature date 6 December 2017

Start date 1 November 2017

End date 28 February 2018

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

BETALIN THERAPEUTICS LTD
Israel